[1] 中国胆固醇教育计划调脂治疗降低心血管事件专家建议(2019)[J]. 中华内科杂志, 2020, 59(1): 18-22. [2] Mach F, Baigent C, Catapano AL, et al.2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk[J]. Eur Heart J, 2020, 41(1):111-188. [3] 诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志,2016, 31(10):937-953. [4] 付强, 李彦鹏. SLCO1B1基因多态性对阿托伐他汀降脂疗效的影响[J]. 中国新药杂志, 2016,25(11):1266-1270. [5] Guan ZW, Wu KR, Li R, et al.Pharmacogenetics of statins treatment:efficacy and safety[J]. J Clin Pharm Ther, 2019 ,44(6): 858-867. [6] Oshiro C, Mangravtte M, Hebert J M, et al.PharmGKB very important pharmacogene: SLCO1B1[J]. Pharmacogenet Gennoics,2010,20(3):211-216. [7] Li C-C, Kanekiyo T, Xu H, et al.apolipoprotein E and Alzheimer disease: risk, mechanism, and therapy[J]. Nature rebiews neurology, 2013,9(2):106-118. [8] Luo JQ, Wen JG, Zhou HH, et al.Endothelialnitric oxide synthase geneg 894 polymorphism and myocardial infarction: ameta-analysis of 34 studies involving 21068 subjects[J]. PLoS One, 2014, 9(1): 87196. [9] 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中华心血管病杂志编辑委员会. 超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识[J]. 中华心血管病杂志, 2020, 48(4): 280-286. [10] Zhong Z, Wu H, Li B, et al.Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China[J]. J Clin Lab Anal, 2018: e22408 [11] 代容. SCLO1B1 521TA>C和388A>G多态性与他汀疗效关系的系统评价和Meta分析[D]. 重庆医科大学, 2015. [12] Herfindal L, Krakstad C, Myhren L, et al.Introduction of aromatic ring-containing substituents in cyclic nucleotides is asociated with inhibition of toxin uptake by the hepatocyte transporters OATP1B1and 1B3[J]. PLoS One, 2014, 9(4): e94926. [13] Larosa JC, Pedersen TR, Somaratne R, et al.Safety and efect of very low levels of low-density lipoprotein cholesterol on cardiovascular events[J]. Am J Cardiol, 2013, 111(8):1221-1229. [14] 王仲朝, 李军, 刘龙梅, 等. SLCO1B1/ApoE基因多态性与瑞舒伐他汀疗效及安全性的相关性研究[J]. 国际生物医学工程杂志, 2016, 39(6): 358-361. [15] 李歆, 徐韫健, 罗娥. 华南地区汉族人群SLCO1B1和ApoE基因多态性分析[J]. 检验医学与临床, 2017, 14(6): 773-775. [16] 刘国栋, 王桦, 汪琦, 等. APOE基因多态性与血脂异常相关性分析[J]. 武汉大学学报(医学版),2017, 38(2): 267-270. [17] 孙谦, 周辉, 郭丽娜. 血脂异常人群ApoE和SLCO1B1基因多态性及相关性研究[J]. 现代检验医学杂志, 2017, 32(6): 28-31. [18] Zended PD, Bankar MP, Kamble PS, et al.Apolipoprotein E gene polymorphism and its effect on plasma lipids in arteriosclerosis[J]. Clin Diagn Res, 2013, 7(10):2149-2152. |